Sinha Uma

Chief Scientific Officer at Eidos Therapeutics, Inc.

Sold, on record
$3.5M
Dollars the filings state
Form 4 sales
8
Latest Jan 13, 2021
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Eidos Therapeutics, Inc.Plan not stated
    May 23, 2019 2019

    Sold 5,000 shares at $27.28 ($136k)

    Sinha Uma, Chief Scientific Officer

    Sold 1.4% of holdings ($9.7M position)349,312 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Eidos Therapeutics, Inc.Plan not stated
    Jul 25, 2019 +63 days

    Sold 5,000 shares at $36.13 ($181k)

    Sinha Uma, Chief Scientific Officer

    Sold 1.4% of holdings ($12.7M position)346,081 shares leftFiling

  3. 3 Form 4 sale Eidos Therapeutics, Inc.Plan not stated
    Sep 25, 2019 +62 days

    Sold 2,500 shares at $38.41 ($96k)

    Sinha Uma, Chief Scientific Officer

    Sold 0.7% of holdings ($13.3M position)343,581 shares leftFiling

  4. 4 Form 4 sale Eidos Therapeutics, Inc.Plan not stated
    Dec 18, 2019 +84 days

    Sold 12,500 shares at $61.90 ($774k)

    Sinha Uma, Chief Scientific Officer

    Sold 3.6% of holdings ($21.3M position)331,081 shares left2.5x usual sizeFiling

  5. 5 Form 4 sale Eidos Therapeutics, Inc.Plan not stated
    Oct 1, 2020 +288 days

    Sold 5,000 shares at $52.34 ($262k)

    Sinha Uma, Chief Scientific Officer

    Sold 1.5% of holdings ($17.4M position)326,525 shares left1x usual sizeFiling

  6. 6 Form 4 sale Eidos Therapeutics, Inc.Plan not stated
    Oct 29, 2020 +28 days

    Sold 5,000 shares at $72.42 ($362k)

    Sinha Uma, Chief Scientific Officer

    Sold 1.5% of holdings ($23.6M position)321,525 shares left1x usual sizeFiling

  7. 7 Form 4 sale Eidos Therapeutics, Inc.Plan not stated
    Dec 2, 2020 +34 days

    Sold 5,000 shares at $90.04 ($450k)

    Sinha Uma, Chief Scientific Officer

    Sold 1.6% of holdings ($28.9M position)316,525 shares left1x usual sizeFiling

  8. 8 Form 4 sale Eidos Therapeutics, Inc.Plan not stated
    Jan 13, 2021 +42 days

    Sold 10,000 shares at $124.32 ($1.2M)

    Sinha Uma, Chief Scientific Officer

    Sold 3.2% of holdings ($39.4M position)306,525 shares left2x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (8)

Form 144 notices and Form 4 sales by Sinha Uma
Source
Jan 13, 2021Jan 15, 2021Eidos Therapeutics, Inc.Chief Scientific OfficerForm 4 sale10,000$1.2M3.2%Plan not statedSEC
Dec 2, 2020Dec 4, 2020Eidos Therapeutics, Inc.Chief Scientific OfficerForm 4 sale5,000$450k1.6%Plan not statedSEC
Oct 29, 2020Oct 30, 2020Eidos Therapeutics, Inc.Chief Scientific OfficerForm 4 sale5,000$362k1.5%Plan not statedSEC
Oct 1, 2020Oct 2, 2020Eidos Therapeutics, Inc.Chief Scientific OfficerForm 4 sale5,000$262k1.5%Plan not statedSEC
Dec 18, 2019Dec 20, 2019Eidos Therapeutics, Inc.Chief Scientific OfficerForm 4 sale12,500$774k3.6%Plan not statedSEC
Sep 25, 2019Sep 27, 2019Eidos Therapeutics, Inc.Chief Scientific OfficerForm 4 sale2,500$96k0.7%Plan not statedSEC
Jul 25, 2019Jul 29, 2019Eidos Therapeutics, Inc.Chief Scientific OfficerForm 4 sale5,000$181k1.4%Plan not statedSEC
May 23, 2019May 28, 2019Eidos Therapeutics, Inc.Chief Scientific OfficerForm 4 sale5,000$136k1.4%Plan not statedSEC